Finesse Solutions announces launch of SmartVessel for cell culture applications

NewsGuard 100/100 Score

Finesse Solutions, Inc, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of beta testing of SmartVessel™, a single-use 3 liter bioreactor vessel with integrated single-use sensors for cell culture applications of mammalian cells, stem cells, insect cells, and plant cells.

This stirred tank single-use bioreactor allows working volumes from 0.5L to 2.2L and is supplied as a completely preassembled and presterilized unit that is immediately ready to use. It eliminates the need for labor-intensive steps such as autoclaving or installation of probes, minimizing the time needed for process setup.

The SmartVessel leverages the same integrated SmartPuck sensor technology for pH, dissolved oxygen (DO) and temperature measurement as the SmartRocker. All wetted materials of the SmartVessel are USP class VI compliant. The SmartVessel also utilizes the same impeller configuration and agitator motor as the Finesse SmartGlass vessels and has been designed to provide almost identical performance in mixing, kLa, and thermal control, but with the efficiency and flexibility of single-use systems. It is both interchangeable with and comparable to in performance with the SmartGlass and readily interchangeable with the SmartRocker when used with the G3lab Universal Controller.

"SmartVessels represent the continued commitment of Finesse to bringing single-use solutions into the lab scale cell-culture market. Along with our SmartRocker and TruFluor pH/DO sensors, the SmartVessel will minimize end user labor in bioreactor cleaning and setup, and maintain fidelity of control. We anticipate that the SmartVessel will provide a unique, complete solution for process development and optimization, as well as production of seed cultures and cell banks," stated Finesse Chief Technology Officer and co-founder, Dr. Mark Selker.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Discovery of new vascular cell type may pave way for novel strategies to treat cardiovascular diseases